Chitosan Nanoparticles for Antiviral Drug Delivery: A Novel Route for COVID-19 Treatment.
Int J Nanomedicine
; 16: 8141-8158, 2021.
Article
in English
| MEDLINE | ID: covidwho-1581579
ABSTRACT
Chitosan has been investigated in several biological fields, including drug and gene delivery, tissue engineering antiviral and immunological adjuvant methods. It's a cationic copolymer of N-acetyl glucosamine and D-glucosamine with different molecular chain lengths, compositions, and sequences than N-acetyl glucosamine and D-glucosamine. It is biocompatible and cyto-compatible, as well as recyclable and bioresorbable. As effective drug delivery methods, chitosan nanoparticles are shaped into several pathways. The purpose of this article is to provide an overview of its antiviral application as a nanocarrier for antiviral medications, highlighting the benefits, limitations, and downsides. In this review, we will report the most recent COVID-19 vaccination advances. It will also be discussed what the future holds for chitosan nanoparticles in the treatment of coronaviruses.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Chitosan
/
Nanoparticles
/
COVID-19 Drug Treatment
Topics:
Vaccines
Limits:
Humans
Language:
English
Journal:
Int J Nanomedicine
Year:
2021
Document Type:
Article
Affiliation country:
Ijn.S332385
Similar
MEDLINE
...
LILACS
LIS